You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Suppliers and packagers for DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ


✉ Email this page to a colleague

« Back to Dashboard


DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 40MEQ dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018037 NDA Baxter Healthcare Company 0338-0663-04 1000 mL in 1 BAG (0338-0663-04) 1979-02-02
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: DEXTROSE 5%, SODIUM CHLORIDE 0.2%, AND POTASSIUM CHLORIDE 40MEQ

Last updated: August 7, 2025


Introduction

The demand for infusion solutions containing Dextrose 5%, Sodium Chloride 0.2%, and Potassium Chloride 40MEQ is steadily increasing across hospitals and clinics globally. These parenteral fluids are vital in rehydration therapy, electrolyte balance, and nutritional supplementation. As pharmaceutical companies and healthcare providers seek reliable, high-quality suppliers, understanding the landscape of manufacturers and distributors becomes crucial. This article provides a comprehensive overview of key suppliers specializing in these components, highlighting their manufacturing capabilities, certifications, geographic reach, and compliance standards.


Overview of the Components

  • Dextrose 5% (Dextrose Monohydrate or Dextrose USP): A carbohydrate solution primarily used for caloric replacement, dehydration correction, and as a vehicle for other drugs.
  • Sodium Chloride 0.2%: An electrolyte solution used in fluid therapy to correct hyponatremia and maintain osmotic balance.
  • Potassium Chloride 40MEQ: An electrolyte supplement essential for cardiac, muscular, and neural functions, often added to intravenous fluids to correct hypokalemia.

These ingredients are combined in sterile, pharmaceutical-grade solutions adhering to stringent USP (United States Pharmacopeia) and EP (European Pharmacopoeia) standards.


Key Supplier Categories

1. Major Multinational Pharmaceutical Manufacturers

Several leading pharmaceutical companies dominate the production of these infusion solutions, primarily due to their extensive R&D, manufacturing capacity, and distribution networks.

  • Baxter International Inc.
    Baxter is a global leader in sterile infusion products. Their portfolio includes dextrose and electrolyte solutions, supplied to hospitals worldwide. Baxter adheres to US FDA and EMA standards, offering high-quality products with robust supply chains.

  • B. Braun Melsungen AG
    B. Braun supplies a range of infusion solutions, including dextrose and electrolyte IV fluids. Their manufacturing plants meet ISO 13485 standards and operate under cGMP compliance, ensuring product consistency and safety.

  • Fresenius Kabi AG
    A key player providing sterile infusion solutions across various formulations. Their products include Dextrose solutions and electrolyte mixes, with manufacturing facilities certified by global health authorities.

  • Hospira (a Pfizer company)
    Specializes in sterile injectable drugs and infusion solutions. Their advanced manufacturing capabilities ensure supply reliability globally.

2. Regional and Local Suppliers

While multinational companies hold significant shares, regional suppliers often provide customized solutions tailored for local regulatory landscapes, especially in developing markets.

  • Vifor Pharma
    Known for electrolytes and infusion solutions, Vifor operates regional manufacturing facilities, especially in Europe and Asia, ensuring local compliance.

  • Kangtai Pharmaceutical Co., Ltd. (China)
    A prominent Chinese manufacturer of infusion solutions, offering competitive pricing and local distribution.

  • Piramal Critical Care (India)
    Provides a range of sterile infusion products, including dextrose and electrolyte solutions, with a strong presence in South Asia and Africa.

3. Contract Manufacturing and Private Label Suppliers

Some firms focus solely on contract manufacturing, producing infusion solutions under third-party brands, often for major pharmaceutical companies.

  • Richland Medical, Inc.
    A US-based contract manufacturer with capabilities in sterile manufacturing, including dextrose and electrolyte solutions.

  • Hainan Yilar Pharmaceutical Co., Ltd. (China)
    Offers OEM services for infusion solutions, adhering to international standards.


Considerations When Sourcing

Regulatory Compliance: Suppliers must demonstrate compliance with US FDA, EMA, and other regional regulatory agencies. Certificates of Analysis (COA), Good Manufacturing Practice (GMP), and ISO certifications are essential indicators.

Quality Assurance & Sterility: Given the injectable nature, sterilization standards—such as terminal sterilization or aseptic processing—are critical.

Supply Chain Reliability: Global supply disruptions, geopolitical issues, and raw material shortages impact supplier reliability. Companies should assess historical performance data.

Pricing and Contract Terms: Competitive pricing, flexible logistics, and after-sales support are key factors influencing selection.


Emerging Trends in Supplier Selection

  • Localization of Production: To reduce dependency on international logistics, companies increasingly seek suppliers with local manufacturing capabilities.
  • Bioequivalence and Generic Manufacturing: Governments promote generics to lower costs, expanding supplier options.
  • Quality Certifications: Suppliers with ISO 13485, cGMP, and WHO-GMP certifications are preferred.
  • Sustainability and Ethical Sourcing: Increasing emphasis on environmentally sustainable manufacturing practices influences supplier choice.

Summary of Notable Suppliers

Supplier Region Certification Product Focus Notes
Baxter International Global FDA, ISO 13485 Dextrose, Electrolytes Extensive global network
B. Braun Global EMA, ISO 13485 IV solutions Known for innovation & reliability
Fresenius Kabi Europe, Asia EMA, ISO 13485 Dextrose, Electrolytes Strong regional manufacturing
Hospira (Pfizer) Global FDA, GMP Intravenous solutions High manufacturing standards
Vifor Pharma Europe, Asia GMP, ISO Electrolyte solutions Focus on electrolyte preparations
Kangtai Pharmaceutical China CFDA, ISO Dextrose, Electrolytes Cost-effective regional supplier
Piramal Critical Care India US FDA, ISO IV fluids Growing global footprint

Conclusion

Selecting reliable suppliers for Dextrose 5%, Sodium Chloride 0.2%, and Potassium Chloride 40MEQ is fundamental for healthcare providers seeking quality, safety, and continuity of supply. Multinational corporations offer assured standards, extensive capacity, and global reach, whereas regional suppliers can provide cost advantages and tailor-made solutions. Due diligence involving regulatory compliance, certification verification, and supply chain assessment remains paramount.


Key Takeaways

  • Leading global suppliers include Baxter, B. Braun, Fresenius Kabi, and Hospira, each maintaining rigorous quality standards compliant with international regulations.
  • Regional manufacturers like Kangtai Pharmaceutical and Piramal Critical Care expand accessible options, especially in emerging markets.
  • Certifications such as GMP, ISO 13485, and WHO-GMP are essential indicators of product quality.
  • Due diligence should emphasize regulatory compliance, manufacturing capacity, logistics, and cost considerations.
  • Emerging trends favor localization, sustainability, and generic manufacturing, broadening the supplier landscape.

FAQs

1. What are the main regulatory standards suppliers must meet for these infusion solutions?
Major suppliers must comply with US FDA regulations, European EMA directives, and international standards like ISO 13485 and GMP to ensure safety, sterility, and efficacy.

2. How does supply chain stability influence supplier choice?
A stable supply chain minimizes risk of shortages, delays, and quality lapses. Companies assess historical reliability and the geographic diversity of manufacturing sites.

3. Are regional suppliers as reliable as multinational corporations?
Regional suppliers can offer reliable, cost-effective solutions, especially if they adhere to international standards and maintain robust certifications. Due diligence is crucial in assessing their capabilities.

4. What certifications indicate high-quality pharmaceutical manufacturing?
Certifications such as Good Manufacturing Practice (GMP), ISO 13485, and WHO-GMP signal adherence to quality and safety standards.

5. How do emerging market suppliers impact global procurement strategies?
They provide cost advantages, reduce lead times, and facilitate local compliance, but require rigorous quality assessments to match international standards.


References

[1] Baxter International Inc. Product Portfolio. Retrieved from [Baxter website]

[2] B. Braun Corporation. Quality Standards and Certifications. Retrieved from [B. Braun website]

[3] Fresenius Kabi. Product Information. Retrieved from [Fresenius Kabi website]

[4] US Food and Drug Administration (FDA). Guidelines on Parenteral Nutrition. Retrieved from [FDA website]

[5] World Health Organization. International Standards for Sterile Injectable Products. Retrieved from [WHO website]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.